More articles from The State of the Art

You have access
A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Clément Morgat, Heying Duan, Simone Dalm, Elif Hindié, Thomas Günther, Bernd J. Krause, Vasko Kramer, Florine Cavelier, Andrew W. Stephens, Stephen Moran, Laura Lamb and Andrei Iagaru

Journal of Nuclear Medicine May 15, 2025, jnumed.124.269444; DOI: https://doi.org/10.2967/jnumed.124.269444
You have access
Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy
Fabio Turco, Silke Gillessen, Ken Herrmann, Gaetano Paone and Aurelius Omlin

Journal of Nuclear Medicine May 1, 2025, 66 (5) 665-672; DOI: https://doi.org/10.2967/jnumed.124.267730
Open Access
Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better
Peter J. Gawne, Helen E. Bryant, Steven G. DuBois, Sally L. George, Juliet Gray, Leona Knox, Kyle B. Matchett, Connie Peet, Katherine A. Vallis, Hugh J. Wallace, Simon Wan and Mark N. Gaze

Journal of Nuclear Medicine April 1, 2025, 66 (4) 490-496; DOI: https://doi.org/10.2967/jnumed.124.269121
You have access
Green Nuclear Medicine and Radiotheranostics
Patrick Veit-Haibach, Ken Herrmann, Richard Zimmermann and Roland Hustinx

Journal of Nuclear Medicine March 1, 2025, 66 (3) 340-343; DOI: https://doi.org/10.2967/jnumed.124.268928
You have access
Navigating Radiation Safety After Radiopharmaceutical Therapies: Proposed Workflow and Essential Guidelines for Nonspecialists
Anna Mench, Celeste Winters, Erik Mittra, Laszlo Szidonya, Catherine Hess, Dennis Barbon and Nadine Mallak

Journal of Nuclear Medicine February 27, 2025, jnumed.124.268522; DOI: https://doi.org/10.2967/jnumed.124.268522
You have access
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy
Vishnu Murthy, Vinicius Ludwig, Andrei Gafita, Thomas A. Hope and Jeremie Calais

Journal of Nuclear Medicine February 27, 2025, jnumed.124.268818; DOI: https://doi.org/10.2967/jnumed.124.268818
You have access
Dosimetry Software for Theranostic Applications: Current Capabilities and Future Prospects
Adam L. Kesner, Julia Brosch-Lenz, Jonathan Gear and Michael Lassmann

Journal of Nuclear Medicine February 1, 2025, 66 (2) 166-172; DOI: https://doi.org/10.2967/jnumed.124.268998
You have access
Nuclear Cardiology Surrogate Biomarkers in Clinical Trials
Robert J.H. Miller, Krishna K. Patel, Jacek Kwiecinski, Leandro Slipczuk, Marc Dweck, David E. Newby, Panithaya Chareonthaitawee and Piotr Slomka

Journal of Nuclear Medicine January 1, 2025, 66 (1) 4-11; DOI: https://doi.org/10.2967/jnumed.124.267869
You have access
Modeling PET Data Acquired During Nonsteady Conditions: What If Brain Conditions Change During the Scan?
Evan D. Morris, Gaelle M. Emvalomenos, Jocelyn Hoye and Steven R. Meikle

Journal of Nuclear Medicine December 1, 2024, 65 (12) 1824-1837; DOI: https://doi.org/10.2967/jnumed.124.267494
Open Access
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson and Oliver Sartor

Journal of Nuclear Medicine November 1, 2024, 65 (11) 1666-1671; DOI: https://doi.org/10.2967/jnumed.124.268363

Main menu

User menu

Search

More articles from The State of the Art

Pages